References
- Johnston C I., Arnolda L, Hiwatari M. Angiotensin converting enzyme inhibitors in the treatment of hypertension. Drugs 1984; 27: 271–7
- Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory congestive heart failure. J Am Coll Cardiol 1983; 2: 755–63
- The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429–35
- The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302
- Pfeffer M A., Braunwald E, Moyé L A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669–77
- Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–6
- Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641–4
- Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–73
- Cushman D W., Cheung H S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1970; 20: 1637–48
- Cushman D W., Wang F L., Fung W C., Harvey C M., DeForrest J M. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. American J Hypertens 1989; 2: 294–306
- Piquilloud Y, Reinharz A, Roth M. Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta 1970; 206: 136–42
- Friedland J, Silverstein E. A sensitive fluorometric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66: 416–24
- Lieberman J, Sastre A. Angiotensin-converting enzyme activity in postmortem human tissues. Lab Invest 1983; 48: 711–7
- Boomsma F, De Bmyn J HB, Derkx F HM, Schalekamp M ADH. Opposite effects of captopril on angiotensin I-converting enzyme ‘activity’ and ‘concentration’; relation between enzyme inhibition and long-term blood pressure response. Clin Sci. 1981; 60: 491–8
- Forslund T, Kouvonen I, Fyhrquist F. Tissue distribution of angiotensin converting enzyme in the rat: effect of captopril treatment. Acta Pharmacol et Toxicol 1984; 54: 124–8
- Johnston C I., Kohzuki M. Angiotensin converting enzyme: localisation, regulation and inhibition. Current Advances in ACE Inhibition,1st edn, G A. MacGregor, P S. Sever. Churchill Livingstone Inc, Edinburgh London Melbourne and New York 1989; 3–7
- Fyhrquist F, Grönhagen-Riska C, Hortling L, Forslund T, Tikkanen I, Klockars M. The induction of angiotensin converting enzyme by its inhibitors. Clin Exp Hypertens [A] 1983; A5(7&8)1319–30